Widening for clopidogrel BE study [Outliers]

posted by Loky do – Egypt, 2021-06-16 17:38 (1205 d 16:13 ago) – Posting: # 22418
Views: 5,496

many Thanks, drgunasakaran1 for your reply

Dears
I also have a question regarding Clopidogrel BE study design, as per ema questions and answers, is widening of Cmax accepted in clopidogrel BE studies with fully replicate design or not?

thanks in advance


Edit: link restored. [mittyri]

Complete thread:

UA Flag
Activity
 Admin contact
23,240 posts in 4,884 threads, 1,652 registered users;
47 visitors (0 registered, 47 guests [including 7 identified bots]).
Forum time: 09:52 CEST (Europe/Vienna)

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5